Stay updated on Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision v3.6.6 has been released, replacing the previous v3.6.5. This appears to be a routine backend update that does not affect the displayed study details.
    Difference
    0.1%
    Check dated 2026-08-30T20:52:39.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision label now reads v3.6.5, replacing the previous v3.6.4.
    Difference
    0.1%
    Check dated 2026-08-09T09:17:56.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Updated the page revision tag from v3.6.3 to v3.6.4, indicating an internal site update. The change represents maintenance or enhancements to the underlying platform rather than to the study details.
    Difference
    0.1%
    Check dated 2026-07-25T23:05:49.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This reflects a software version update of the page rather than a change to trial content.
    Difference
    0.1%
    Check dated 2026-07-04T13:23:37.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page shows a revision from v3.6.0 to v3.6.2. This appears to be a minor update to the ClinicalTrials.gov page, likely including small fixes or UI tweaks without changing study details.
    Difference
    0.1%
    Check dated 2026-06-27T04:47:02.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate no further participant enrollment. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) are added, and the Intervention/Treatment label is updated while older labels and revision text are removed.
    Difference
    0.5%
    Check dated 2026-06-13T05:13:24.000Z thumbnail image

Stay in the know with updates to Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab in Prostate or Endometrial Cancer Clinical Trial page.